Omega Healthcare Ownership

OHI Stock  USD 36.40  0.05  0.14%   
Omega Healthcare owns a total of 281.84 Million outstanding shares. The majority of Omega Healthcare Investors outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Omega Healthcare Inv to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Omega Healthcare. Please pay attention to any change in the institutional holdings of Omega Healthcare Inv as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
2009-03-31
Previous Quarter
262 M
Current Value
276 M
Avarage Shares Outstanding
178.6 M
Quarterly Volatility
62.7 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Some institutional investors establish a significant position in stocks such as Omega Healthcare in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Omega Healthcare, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omega Healthcare Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Omega Stock Ownership Analysis

About 77.0% of the company shares are owned by institutional investors. The book value of Omega Healthcare was now reported as 16.25. The company has Price/Earnings To Growth (PEG) ratio of 1.13. Omega Healthcare Inv last dividend was issued on the 10th of February 2025. Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. The assets span all regions within the US, as well as in the UK. Omega Healthcare operates under REITHealthcare Facilities classification in the United States and is traded on New York Stock Exchange. It employs 70 people. To find out more about Omega Healthcare Investors contact Taylor CPA at 410 427 1700 or learn more at https://www.omegahealthcare.com.
Besides selling stocks to institutional investors, Omega Healthcare also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Omega Healthcare's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Omega Healthcare's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Omega Healthcare Quarterly Liabilities And Stockholders Equity

9.06 Billion

Omega Healthcare Insider Trades History

Less than 1% of Omega Healthcare Investors are currently held by insiders. Unlike Omega Healthcare's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Omega Healthcare's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Omega Healthcare's insider trades
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Omega Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Omega Healthcare is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Omega Healthcare Investors backward and forwards among themselves. Omega Healthcare's institutional investor refers to the entity that pools money to purchase Omega Healthcare's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Norges Bank2024-12-31
2.9 M
Bank Of America Corp2024-09-30
2.8 M
Centersquare Investment Management Llc2024-12-31
2.7 M
Northern Trust Corp2024-09-30
2.2 M
Balyasny Asset Management Llc2024-09-30
2.1 M
Morgan Stanley - Brokerage Accounts2024-09-30
2.1 M
Amundi2024-12-31
M
Ubs Asset Mgmt Americas Inc2024-09-30
1.7 M
Legal & General Group Plc2024-12-31
1.6 M
Vanguard Group Inc2024-12-31
38.1 M
Blackrock Inc2024-09-30
31.9 M
Note, although Omega Healthcare's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Omega Healthcare Inv Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Omega Healthcare insiders, such as employees or executives, is commonly permitted as long as it does not rely on Omega Healthcare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Omega Healthcare insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Omega Healthcare Outstanding Bonds

Omega Healthcare issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Omega Healthcare Inv uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Omega bonds can be classified according to their maturity, which is the date when Omega Healthcare Investors has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Omega Healthcare Corporate Filings

10K
13th of February 2025
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
ViewVerify
6th of February 2025
Other Reports
ViewVerify
F4
21st of January 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F3
10th of January 2025
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify

Currently Active Assets on Macroaxis

When determining whether Omega Healthcare Inv offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Omega Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Omega Healthcare Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Omega Healthcare Investors Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omega Healthcare Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omega Healthcare. If investors know Omega will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omega Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.838
Dividend Share
2.68
Earnings Share
1.55
Revenue Per Share
4.073
Quarterly Revenue Growth
0.167
The market value of Omega Healthcare Inv is measured differently than its book value, which is the value of Omega that is recorded on the company's balance sheet. Investors also form their own opinion of Omega Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Omega Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omega Healthcare's market value can be influenced by many factors that don't directly affect Omega Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omega Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omega Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omega Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.